Tralokinumab: Discovering the Possibility of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a promising treatment for severe dermatitis. This humanized antibody inhibits https://lealidl397928.blog-gold.com/profile